✦ LIBER ✦

Histopathology of pediatric nonalcoholic fatty liver disease

✍ Scribed by Jeffrey B. Schwimmer; Cynthia Behling; Robert Newbury; Reena Deutsch; Caroline Nievergelt; Nicholas J. Schork; Joel E. Lavine

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 460 KB
Volume: 42
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.20842

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The histopathology of pediatric nonalcoh

The histopathology of pediatric nonalcoholic fatty liver disease

✍ Jean Pappas Molleston 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB 👁 2 views

Nonalcoholic fatty liver disease after l

Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease

✍ Kanthi Yalamanchili; Sherif Saadeh; Göran B. Klintmalm; Linda W. Jennings; Gary 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples

Functional and morphological vascular ch

Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease

✍ Lucia Pacifico; Caterina Anania; Francesco Martino; Vito Cantisani; Roberto Pasc 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views

Nonalcoholic fatty liver disease (NAFLD) has been consistently found to be associated with features of the metabolic syndrome (MS), a condition carrying a high risk of cardiovascular events. The present study aimed to determine whether, in children and adolescents, NAFLD is atherogenic beyond its as

Nonalcoholic fatty liver disease and liv

Nonalcoholic fatty liver disease and liver transplantation

✍ Paul Angulo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre

Liver enzymes, nonalcoholic fatty liver

Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease

✍ Giovanni Targher; Christopher P. Day 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 1 views

Valproate therapy and nonalcoholic fatty

Valproate therapy and nonalcoholic fatty liver disease

✍ Gerhard J. Luef; Markus Waldmann; Wolfgang Sturm; Anis Naser; Eugen Trinka; Iris 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract Nonalcoholic fatty liver disease was defined recently as another symptom of insulin resistance. Continuous therapy with valproate can result in increased body weight and insulin resistance, but no data are yet available on a possible relationship between valproate and nonalcoholic fatty